Jimmy's biotech company was doing well. A deal was on the
table for a massive pharma conglomerate, Massive-Pharm, to purchase
his company via an asset purchase agreement. Everything was going
well, that is, until Jimmy's top sales star, Terry, leveraged
the impending purchase to secure a better-paying position at
Jimmy's competitor. After Jimmy's company lost Terry,
Massive-Pharm pulled the deal.
Believe it or not, Jimmy's situation is not an entirely
uncommon one in the M&A world. Purchase agreements often
contain legal clauses allowing acquiring companies to back out of
deals should the target company lose key employees prior to
closing. This legal reality creates a measure of risk for companies
in the midst of M&A. What's more, the exodus of key
personnel surrounding M&A deals can not only endanger the
success of transactions themselves, but can also endanger the
long-term success of companies whose deals have closed. PwC makes note of the "high value"
of